Exhibit on local Native Americans opens at museum

By Hadley Barndollar, The Associated Press

PORTSMOUTH, N.H. — As some states and communities have slowly begun to acknowledge their often purposeful erasure of Native Americans from the dominant narrative, the voices, cultures and histories of the Abenaki and Wabanaki peoples were recently given a rightful home in the oldest “neighbourhood” of New Hampshire settled by Europeans.

“People of the Dawnland,” an exhibit at the Jones House Family Discover Center in the 1600s Puddle Dock neighbourhood, opens this month. The neighbourhood, now known far and wide as Strawbery Banke Museum, did in fact have remnants of indigenous people, such as pottery, projectile points and tent holes, discovered by archaeologists, but the museum has largely focused its efforts on the colonial aspects of the early settlement.

But the narrative is changing, after a long-range interpretive planning effort targeted elevating diverse voices in their collections as a goal for the museum. Alix Martin, museum archaeologist and non-Native professor of Native Studies in the anthropology department at the University of New Hampshire, said the American Alliance of Museums issued a “trend watch” for the year, which included a large section about “decolonizing museums,” by not focusing solely on colonial and Anglo-American narratives.

The archaeological discoveries showed indigenous people have been in the region for more than 12,000 years.

The rehabilitation of two Strawbery Banke houses over the last year resulted in some exhibit movement, and a room in the Jones House arose as a proper opportunity to debut the Native American-focused display, which is interactive, incorporating hands-on activities, such as games, art and storytelling.

The exhibit was organized by the museum’s education department in collaboration with Martin and Anne Jennison, a Strawbery Banke interpreter of European and Abenaki ancestry, known for her traditional Northeast Native American storytelling. Input for the exhibit was provided by the state Commission on Native American Affairs, tribes, the Berwick, Maine, Historical Society, and the Indigenous New Hampshire Collaborative Collective at UNH.

Jennison said she asked her parents for permission to publicly identify as a Native person before she began her storytelling endeavours 30 years ago. “If you could identify as white or black, it was better than identifying as Native,” Jennison said. “It was safer. It’s only very recent in the history of New England that it’s OK. There is a lot of scholarship about how the New England Native peoples have been hiding in plain sight.”

Detailed in a documentary last year titled “Dawnland,” in Maine, government agents systematically forced Native American children from their homes and placed them with white families. As recently as the 1970s, one in four Native children nationwide were living in non-Native foster care, adoptive homes or at boarding schools. The separation caused emotional and physical harm as adults attempted to erase their cultural identity.

Jennison is also a Native craftswoman, and the exhibit features her birch bark creations, corn husk dolls and bead work. A library for browsing showcases Native literature of all kinds. Various archaeological artifacts are on display, and interpretative wall panels detail Native history on the Seacoast and across New Hampshire. There is also a formal land acknowledgement, signifying Abenaki land underfoot.

The exhibit features donations from personal collections, and an Abenaki artist allowed her work to be shown on the walls. Native foodways are depicted by Indian corn, beans and squash. Jennison said the presentation draws from “everyone’s bag of tools.”

“People were curious, ‘Why is your history starting only with the 1600s?'” Martin said. “I think this is a great opportunity to go way farther back and start with the very first people who lived here. And then connect these people and their connection to this landscape and their traditions to today. Native people were and are an important part of the Portsmouth and Puddle Dock community.”

Jennison grew up in Portsmouth, and had a goal that after she retired from teaching, she would approach Strawbery Banke about expanding its focus on Native American history. Jennison’s master’s work at UNH focused largely on the 1713 Treaty of Portsmouth, which represented an important agreement between the “Eastern Indians” and the English Royal government. The treaty shows pictograph signatures of tribal delegates attending the peace conference, including the Abenaki sachem, Bomoseen.

When English colonists began to arrive in the Northeast in the 1600s, bringing foreign diseases, animals and plants onto Abenaki homeland, violent conflicts across the region resulted in the deaths of Native people, and the removal of others from their homeland. But many Abenaki people remained and adapted, showing strength and resilience.

Martin said she is confident the exhibit reflects what Native Americans want to communicate, thanks to the widespread input they received in curating it. She also noted the Native population in New Hampshire is actually growing, because of new identification options offered by the Census Bureau.

“Allowing people to identify themselves as Native has brought so many more people in touch with their heritage,” Martin said. “For a long time it was a strategy thing, to not be allowed to identify as Native. A lot of people were erased from census records, so it’s really gratifying to see people reconnecting with it. I would not be surprised if the number in New Hampshire doubled through 2020.”

Today, there are more than 7,000 Native Americans and Alaska Natives living in New Hampshire.

Martin said at UNH, it wasn’t until the Indigenous New Hampshire Collaborative Collective began to gain momentum that some faculty members began to openly identify as of indigenous descent. As a non-Native person teaching Native studies, Martin noted she tries to be extremely conscious “of me not being the voice on Native people.”

Lawrence J. Yerdon, president and CEO of Strawbery Banke, said it has “long been a goal of the museum to expand its interpretation of the Abenaki people.”

“Depending on how things go, it’s been indicated it could grow from here,” Jennison said. “What we’ve got here is a really good beginning.”

It’s estimated approximately 95,000 people visit Strawbery Banke over the course of one year.

This week, Maine officially replaced Columbus Day with Indigenous Peoples’ Day, with the signature of Gov. Janet Mills. According to the New York Times, at least six states and 130 cities and towns have now renamed the holiday, which as Columbus Day, has been a federal holiday since 1934. Italian explorer Christopher Columbus reportedly committed atrocities against Native people, and many feel the holiday glorifies him over those who inhabited the land prior.

In New Hampshire, the future of the holiday isn’t so certain. In February, legislators put off deciding whether Columbus Day would be renamed. House Bill 221 remains stalled. The town of Durham is believed to be the first in the state to vote in favour of the switch to Indigenous Peoples’ Day.

“People of the Dawnland” is open seven days a week, from 10 a.m. to 5 p.m., and is included in regular museum admission.

Online: https://bit.ly/2VjVVMP

___

Information from: Portsmouth Herald, http://www.seacoastonline.com

Hadley Barndollar, The Associated Press

Keep it Factual
Add CityNews Toronto as a trusted source on Google to see more local stories from us.

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

1h ago

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

1h ago

Most Watched Today